Quinotolast

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameQuinotolast
Drug Alias NameQuinotolast sodium (Rec INNM)AslockFK-021FR-71021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsAsthmaPeptic UlcerIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsAsthmaPeptic UlcerIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A